The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive value of the patient reported outcome “living with cancer” instrument on overall survival in advanced cancer patients: A tool for guiding timing of palliative care consultations.
 
Stuart L. Goldberg
Employment - COTA
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Celgene; Novartis
Research Funding - Ambit BioSciences (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Novartis
 
Dhakshila Paramanathan
Employment - COTA
 
Srikesh Arunajadai
Employment - COTA
 
Victoria DeVincenzo
Employment - COTA
 
Ruth Pe Benito
Employment - COTA
 
Brooke Gruman
Employment - COTA
 
Sukhi Kaur
Employment - COTA
 
Andre Goy
Honoraria - Acerta Pharma; Celgene; Pharmacyclics; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Infinity Pharmaceuticals; Pharmacyclics; Takeda
Speakers' Bureau - Pharmacyclics; Takeda
Research Funding - Clinical Trials Through Institution
 
Usha Niranjan
No Relationships to Disclose
 
Denis Fitzgerald
No Relationships to Disclose
 
Julianne Wilkins Childs
No Relationships to Disclose
 
James W. Lee
No Relationships to Disclose
 
May D. Abdo-Matkiwsky
No Relationships to Disclose
 
Kelly Choi
Employment - COTA
 
John Hervey
Employment - COTA
Leadership - COTA
 
Eric Schultz
Employment - COTA
Leadership - COTA
 
Andrew Pecora
Leadership - Caladrius Biosciences; COTA
Stock and Other Ownership Interests - Caladrius Biosciences; COTA
Patents, Royalties, Other Intellectual Property - COTA